Recent evidence demonstrates hypertrophic cardiomyopathy is more prevalent than previously estimated. Advances in imaging technology and genetic testing enable prompt diagnosis if clinicians can detect suspected disease. Improved detection is critical to address treatment gaps and improve quality of life for patients.

This course will help you sharpen your diagnostic skills to recognize the characteristic signs and symptoms of hypertrophic cardiomyopathy. Our expert faculty will share the latest advancements in diagnosis and emerging therapies to provide timely treatment to patients with this underrecognized disease.

Certified Patient Cases

Test your knowledge and sharpen your diagnostic skills to recognize these life-threatening conditions earlier and bring appropriate treatment to your patients sooner.

 
   
Self-Paced Learning

Dive into this engaging eLearning curriculum to increase recognition and detection of hypertrophic cardiomyopathy to accelerate diagnosis and treatment.

 



  
Webinar

Join expert faculty Matthew W. Martinez, MD, FACC, Dermot Phelan, MD, FACC, and Lisa Salberg for this session to forge a new path to detect and diagnose cardiomyopathies and accelerate treatment to improve patient outcomes.

 


  
Click here to see additional Spotlight Topics in the Clinical Spotlight Series

We are grateful to these distinguished Members of the American College of Cardiology who contributed to this collection:

Matthew W. Martinez, MD, FACC

Dermot Phelan, MD, FACC

Lisa Salberg

Carolyn Ho, MD, FACC – (certified patient case author, not involved in the webinar)


Michael Scott Emery, MD, FACC – (certified patient case author, not involved in the webinar)

Sara Saberi, MD  – (certified patient case author, not involved in the webinar)

Supported by: Akcea Therapeutics, Inc., Alnylam Pharmaceuticals, MyoKardia, and Pfizer, Inc.
Powered By